We are live on ! Find out more
TECH icon

Bio-Techne

332 hedge funds and large institutions have $5.43B invested in Bio-Techne in 2018 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 103 increasing their positions, 110 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

174% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 23

30% more call options, than puts

Call options by funds: $1.89M | Put options by funds: $1.45M

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

15% more capital invested

Capital invested by funds: $4.72B → $5.43B (+$710M)

12% more funds holding

Funds holding: 297332 (+35)

6% less repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 110

5.21% less ownership

Funds ownership: 388.84%383.63% (-5.2%)

Holders
332
Holders Change
+35
Holders Change %
+11.78%
% of All Funds
7.61%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
63
Increased
103
Reduced
110
Closed
23
Calls
$1.89M
Puts
$1.45M
Net Calls
+$434K
Net Calls Change
+$564K
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$55.9M +$2.02M +57,200 +4%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$51.6M +$604K +17,088 +1%
Lord, Abbett & Co
28
Lord, Abbett & Co
New Jersey
$48.5M +$276K +7,816 +0.6%
SBH
29
Segall Bryant & Hamill
Illinois
$46.9M -$5.11M -144,732 -10%
EIP
30
Epoch Investment Partners
New York
$40.4M -$1.85M -52,336 -5%
CCA
31
Conestoga Capital Advisors
Pennsylvania
$39.4M -$1.99M -56,200 -5%
Charles Schwab
32
Charles Schwab
California
$37.4M +$5.78M +163,572 +20%
Bank of America
33
Bank of America
North Carolina
$36.8M -$2.66M -75,192 -7%
Principal Financial Group
34
Principal Financial Group
Iowa
$33.5M +$3.3M +93,416 +12%
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
$31.8M +$1.04M +29,568 +4%
Schroder Investment Management Group
36
Schroder Investment Management Group
United Kingdom
$31.1M -$9.33M -264,168 -24%
Macquarie Group
37
Macquarie Group
Australia
$29.7M +$575K +16,284 +2%
SEI Investments
38
SEI Investments
Pennsylvania
$26.3M -$8.5M -240,444 -26%
Wellington Management Group
39
Wellington Management Group
Massachusetts
$25.9M -$113K -3,188 -0.5%
O
40
OppenheimerFunds
New York
$23.1M -$25.7K -728 -0.1%
CBOA
41
Commonwealth Bank of Australia
Australia
$23.1M +$25.3K +716 +0.1%
SCP
42
Sandhill Capital Partners
New York
$22.8M +$21.3M +603,784 New
FA
43
Friess Associates
Delaware
$22.5M +$557K +15,764 +3%
BTW
44
Boston Trust Walden
Massachusetts
$20.8M -$1.13M -32,004 -5%
Goldman Sachs
45
Goldman Sachs
New York
$20.1M -$12.8M -361,596 -40%
Public Employees Retirement Association of Colorado
46
Public Employees Retirement Association of Colorado
Colorado
$19.4M -$4.99M -141,288 -22%
DIA
47
Denver Investment Advisors
Colorado
$19M -$981K -27,768 -5%
TCIM
48
TIAA CREF Investment Management
New York
$18.4M +$635K +17,972 +4%
KCM
49
Kornitzer Capital Management
Kansas
$18.3M -$1.81M -51,140 -10%
SCA
50
Summit Creek Advisors
Minnesota
$18M +$1.93M +54,548 +13%

TECH Hedge Fund Activity: Q1 2018 in Review

332 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2018, worth a combined $5.43B — up 15% from $4.72B a quarter earlier.

Buyers outnumbered sellers: 63 funds opened new TECH positions and 23 closed out — a net gain of 40 holders — while 103 added to existing stakes and 110 trimmed.

The largest buyer was Massachusetts Financial Services, adding an estimated $53.1M. The largest seller was Select Equity Group, cutting an estimated $96.4M.

  • 332 institutional investors held Bio-Techne (TECH) as of Q1 2018, up from 297 in Q4 2017.
  • Funds reported $5.43B of Bio-Techne stock for Q1 2018, up 15% quarter-over-quarter.
  • 63 funds opened new Bio-Techne positions in Q1 2018 and 23 closed out, a net change of +40 holders.
  • The largest Bio-Techne buyer in Q1 2018 was Massachusetts Financial Services, an estimated $53.1M added.
  • The largest Bio-Techne seller in Q1 2018 was Select Equity Group, an estimated $96.4M sold.

Based on aggregated 13F filings for Q1 2018.